Amy E DeZern

13PUBLICATIONS
87CO-AUTHORS
Gene and molecular therapyHaematological tumoursPredictive and prognostic markersMolecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Feb 16, 2026
Modeling the evolutionary dynamics of clonal hematopoiesis.

Sadegh Marzban, Thomas Stiehl, Zhuoer Xie

|Feb 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for BCR-ABL B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation.

John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur

|Dec 03, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

Carmelo Gurnari, Hideki Makishima, Arda Durmaz

|Nov 24, 2025
A PBD-dimer containing antibody drug conjugate targeting CCRL2 for high-risk MDS/AML.

Theodoros Karantanos, Nour Naji, Taha Ahmedna

|Nov 14, 2024
Imetelstat: a new addition to the therapeutic landscape of lower-risk MDS.

Yasmin Abaza, Amy E DeZern

Pageof 3

Frequent Collaborators

3 joint publications

Alexander J Ambinder

2 joint publications

Theodoros Karantanos

2 joint publications

Yasuhito Nannya

2 joint publications

Yasmin Abaza